Oral Peroxisome Proliferator–Activated Receptor-α Agonist Enhances Corneal Nerve Regeneration in Patients With Type 2 Diabetes

Diabetic corneal neuropathy (DCN) is a common complication of diabetes. However, there are very limited therapeutic options. We investigated the effects of a peroxisome proliferator–activated receptor-α (PPAR-α) agonist, fenofibrate, on 30 patients (60 eyes) with type 2 diabetes. On in vivo confocal...

Descripción completa

Detalles Bibliográficos
Autores principales: Teo, Calesta Hui Yi, Lin, Molly Tzu-Yu, Lee, Isabelle Xin Yu, Koh, Siew-Kwan, Zhou, Lei, Goh, Dylan Shaoying, Choi, Hyungwon, Koh, Hiromi Wai Ling, Lam, Amanda Yun Rui, Lim, Paik Shia, Mehta, Jodhbir S., Kovalik, Jean-Paul, Coffman, Thomas M., Tan, Hong Chang, Liu, Yu-Chi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2023
Materias:
Complications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10281232/
https://www.ncbi.nlm.nih.gov/pubmed/36445944
http://dx.doi.org/10.2337/db22-0611

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10281232/
https://www.ncbi.nlm.nih.gov/pubmed/36445944
http://dx.doi.org/10.2337/db22-0611

Ejemplares similares